Cardiff Oncology, Inc.
CRDF
$1.79
-$0.03-1.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.30M | 60.59M | 70.96M | 79.89M | 91.75M |
| Total Receivables | 482.00K | 254.00K | 526.00K | 405.00K | 1.17M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.34M | 956.00K | 2.21M | 2.42M | 2.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 60.13M | 61.80M | 73.70M | 82.71M | 95.05M |
|
|
|||||
| Total Current Assets | 60.13M | 61.80M | 73.70M | 82.71M | 95.05M |
| Net Property, Plant & Equipment | 1.21M | 1.43M | 1.64M | 1.84M | 2.07M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 549.00K | 549.00K | 401.00K | 257.00K | 69.00K |
| Total Assets | 61.88M | 63.78M | 75.74M | 84.81M | 97.19M |
|
|
|||||
| Total Accounts Payable | 8.09M | 2.44M | 6.01M | 3.63M | 4.82M |
| Total Accrued Expenses | 7.58M | 11.54M | 9.94M | 8.04M | 7.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 730.00K | 726.00K | 721.00K | 716.00K | 710.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 902.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 902.00K | -- |
| Total Current Liabilities | 16.39M | 14.71M | 16.67M | 13.29M | 13.43M |
|
|
|||||
| Total Current Liabilities | 16.39M | 14.71M | 16.67M | 13.29M | 13.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 102.00K | 284.00K | 464.00K | 640.00K | 813.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.50M | 14.99M | 17.13M | 13.93M | 14.24M |
|
|
|||||
| Common Stock & APIC | 475.37M | 471.55M | 470.15M | 468.46M | 467.09M |
| Retained Earnings | -430.03M | -422.81M | -411.56M | -397.61M | -384.18M |
| Treasury Stock & Other | 50.00K | 50.00K | 17.00K | 27.00K | 34.00K |
| Total Common Equity | 45.39M | 48.79M | 58.61M | 70.88M | 82.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.39M | 48.79M | 58.61M | 70.88M | 82.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.39M | 48.79M | 58.61M | 70.88M | 82.95M |
|
|
|||||